138 related articles for article (PubMed ID: 23572161)
1. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.
Garand M; Lin JH; Hill CE; Zagorac B; Koschinsky ML; Boffa MB
Cytokine; 2012 Mar; 57(3):389-97. PubMed ID: 22217421
[TBL] [Abstract][Full Text] [Related]
3. The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.
Lin JH; Novakovic D; Rizzo CM; Zagorac B; Garand M; Filipieva A; Koschinsky ML; Boffa MB
Thromb Haemost; 2013 Jun; 109(6):1033-44. PubMed ID: 23595589
[TBL] [Abstract][Full Text] [Related]
4. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
Masuda Y; Yazawa J; Makino Y; Takada K
Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.
Masuda Y; Saotome D; Takada K; Sugimoto K; Sasaki T; Ishii H
Thromb Haemost; 2012 Jul; 108(1):74-85. PubMed ID: 22535242
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter.
Garand M; Bastajian N; Nesheim ME; Boffa MB; Koschinsky ML
Br J Haematol; 2007 Jul; 138(2):231-44. PubMed ID: 17593031
[TBL] [Abstract][Full Text] [Related]
8. Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells.
Lin JH; Garand M; Zagorac B; Schadinger SL; Scipione C; Koschinsky ML; Boffa MB
Thromb Haemost; 2011 Jun; 105(6):999-1009. PubMed ID: 21505719
[TBL] [Abstract][Full Text] [Related]
9. Expression of thrombin-activatable fibrinolysis inhibitor (TAFI) is up-regulated by increase in intracellular cyclic AMP levels in cultured HepG2 cells.
Ishii H; Kojima Y; Masuda Y; Takada K; Sugimoto K; Ikeda T
Thromb Haemost; 2009 Dec; 102(6):1204-11. PubMed ID: 19967152
[TBL] [Abstract][Full Text] [Related]
10. Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3'-untranslated region.
Novakovic D; Kuo AC; Lin JH; Koschinsky ML; Boffa MB
J Thromb Haemost; 2012 May; 10(5):887-94. PubMed ID: 22452791
[TBL] [Abstract][Full Text] [Related]
11. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.
Boffa MB; Hamill JD; Maret D; Brown D; Scott ML; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Mar; 278(11):9250-7. PubMed ID: 12645517
[TBL] [Abstract][Full Text] [Related]
12. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).
Boffa MB; Reid TS; Joo E; Nesheim ME; Koschinsky ML
Biochemistry; 1999 May; 38(20):6547-58. PubMed ID: 10350473
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone.
Garand M; Lin JH; Zagorac B; Koschinsky ML; Boffa MB
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):393-404. PubMed ID: 23429253
[TBL] [Abstract][Full Text] [Related]
15. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
16. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
17. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
Stasko J; Hudecek J; Kubisz P
Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
[TBL] [Abstract][Full Text] [Related]
18. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
19. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
[TBL] [Abstract][Full Text] [Related]
20. Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1β-treated hepatocytes.
Yoshigai E; Machida T; Okuyama T; Mori M; Murase H; Yamanishi R; Okumura T; Ikeya Y; Nishino H; Nishizawa M
Biochem Biophys Res Commun; 2013 Sep; 439(1):54-9. PubMed ID: 23958298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
